The Department of Pharmacology engages in the development of therapeutic strategies for the prevention and/or amelioration of the damages induced following exposure to different toxicants.
We perform multi-system research toward the development of treatments that can significantly decrease acute and chronic damages following exposure, in a variety of exposure models. The selection of the potential treatments is performed in a rational way, based on the results of investigations that characterized the injuries sustained by the different body systems.
We also engage in R&D in the development of treatments using induced pluripotent stem cells as a local treatment to prevent damage and/or for the rehabilitation of pathologies in specific organs following focused exposure, or against multi-system damage following whole body exposure.
The following are a few of the treatment solutions that were developed in our department:
1. Localin (benoxinate HCL 0.4%) treatment following sulfur mustard exposure, was found to relieve pain, enabling eye opening and therefore allowing self-evacuation.
2. Topical treatment with the steroid dexamycin (dexamethasone) following sulfur mustard ocular exposure, significantly reduced the acute as well as long-term pathologies.
3. Combined treatment with an auto-injector, TAB, containing TMB4, atropine and benactizine was found as an effective counter-measure against organophosphate intoxication.
4. Topical treatment with a combination of the steroid betacorten (betamethasone cream 0.1%) and the non-steroidal anti-inflammatory voltaren (diclofenac 1%) significantly reduced acute skin injury following dermal exposure to sulfur mustard in vapor or liquid form.
We welcome you to contact us for any question or offer for collaborations.
There are some errors in your form.
the mail is recived, thank you